Allergan Beats Miotox's $600M Botox Royalty Claims
A California federal judge on Monday granted Allergan Inc.'s motion for summary judgment in a $600 million breach-of-contract lawsuit over Botox, holding that the pharmaceutical giant does not have to pay...To view the full article, register now.
Already a subscriber? Click here to view full article